180 related articles for article (PubMed ID: 23237571)
21. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice.
Mohammed A; Janakiram NB; Brewer M; Duff A; Lightfoot S; Brush RS; Anderson RE; Rao CV
Neoplasia; 2012 Dec; 14(12):1249-59. PubMed ID: 23308056
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.
Lee S; Das HK
Brain Res; 2008 May; 1207():19-31. PubMed ID: 18374905
[TBL] [Abstract][Full Text] [Related]
23. JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages.
Nieminen R; Lahti A; Jalonen U; Kankaanranta H; Moilanen E
Int Immunopharmacol; 2006 Jun; 6(6):987-96. PubMed ID: 16644485
[TBL] [Abstract][Full Text] [Related]
24. c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.
Shen K; Ji L; Lu B; Wang Z
Cell Biochem Biophys; 2012 Sep; 64(1):17-27. PubMed ID: 22592917
[TBL] [Abstract][Full Text] [Related]
25. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD.
Kook SH; Son YO; Jang YS; Lee KY; Lee SA; Kim BS; Lee HJ; Lee JC
Toxicol Appl Pharmacol; 2008 Mar; 227(3):468-76. PubMed ID: 18078968
[TBL] [Abstract][Full Text] [Related]
27. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
Yoon CH; Kim MJ; Kim RK; Lim EJ; Choi KS; An S; Hwang SG; Kang SG; Suh Y; Park MJ; Lee SJ
Oncogene; 2012 Nov; 31(44):4655-66. PubMed ID: 22249269
[TBL] [Abstract][Full Text] [Related]
28. Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Ruscetti S
J Virol; 2005 Oct; 79(20):12752-62. PubMed ID: 16188978
[TBL] [Abstract][Full Text] [Related]
29. Activating P2X7 Receptors Increases Proliferation of Human Pancreatic Cancer Cells via ERK1/2 and JNK.
Choi JH; Ji YG; Ko JJ; Cho HJ; Lee DH
Pancreas; 2018; 47(5):643-651. PubMed ID: 29683976
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
Minutoli L; Altavilla D; Marini H; Passaniti M; Bitto A; Seminara P; Venuti FS; Famulari C; Macrì A; Versaci A; Squadrito F
Life Sci; 2004 Oct; 75(24):2853-66. PubMed ID: 15454338
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis and cell cycle arrest by a specific c-Jun NH2-terminal kinase (JNK) inhibitor, SP-600125, in gastrointestinal cancers.
Xia HH; He H; De Wang J; Gu Q; Lin MC; Zou B; Yu LF; Sun YW; Chan AO; Kung HF; Wong BC
Cancer Lett; 2006 Sep; 241(2):268-74. PubMed ID: 16337741
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST
Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660
[TBL] [Abstract][Full Text] [Related]
33. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.
Li DD; Wang LL; Deng R; Tang J; Shen Y; Guo JF; Wang Y; Xia LP; Feng GK; Liu QQ; Huang WL; Zeng YX; Zhu XF
Oncogene; 2009 Feb; 28(6):886-98. PubMed ID: 19060920
[TBL] [Abstract][Full Text] [Related]
34. Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801.
Dougherty MC; Shibata SB; Clark JJ; Canady FJ; Yates CW; Hansen MR
J Neurosurg; 2023 Apr; 138(4):962-971. PubMed ID: 36087315
[TBL] [Abstract][Full Text] [Related]
35. NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways.
Yao J; Weng Y; Yan S; Hou M; Wang H; Shi Q; Zuo G
Oncol Rep; 2015 Oct; 34(4):2011-21. PubMed ID: 26238193
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells.
Ohba S; Hirose Y; Kawase T; Sano H
J Neurooncol; 2009 Dec; 95(3):307-316. PubMed ID: 19517066
[TBL] [Abstract][Full Text] [Related]
37. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y
Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120
[TBL] [Abstract][Full Text] [Related]
38. Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.
Wang J; Ni WH; Hu KB; Zhai XY; Xie F; Jie J; Zhang NN; Jiang LN; Yuan HY; Tai GX
Cancer Sci; 2017 Mar; 108(3):504-511. PubMed ID: 28012230
[TBL] [Abstract][Full Text] [Related]
39. [Down-regulated expression of PP2A catalytic subunit in pancreatic cancer cells promotes cell growth].
Li W; Gong F; Chen Z; Zong Y; Chen K; Li D; Tao M; Xu Z
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):86-9. PubMed ID: 24721345
[TBL] [Abstract][Full Text] [Related]
40. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R
Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]